Qingfeng Cheng

663 total citations
18 papers, 383 citations indexed

About

Qingfeng Cheng is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Qingfeng Cheng has authored 18 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Qingfeng Cheng's work include Hormonal Regulation and Hypertension (7 papers), Adrenal and Paraganglionic Tumors (5 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers). Qingfeng Cheng is often cited by papers focused on Hormonal Regulation and Hypertension (7 papers), Adrenal and Paraganglionic Tumors (5 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers). Qingfeng Cheng collaborates with scholars based in China, Australia and Italy. Qingfeng Cheng's co-authors include Qifu Li, Shumin Yang, Ying Song, Hao Liu, Jun Luo, Jinbo Hu, Zhen Yuan, Linqiang Ma, Jun Ki Min and Kai Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

Qingfeng Cheng

16 papers receiving 379 citations

Peers

Qingfeng Cheng
Qingfeng Cheng
Citations per year, relative to Qingfeng Cheng Qingfeng Cheng (= 1×) peers Monika Rać

Countries citing papers authored by Qingfeng Cheng

Since Specialization
Citations

This map shows the geographic impact of Qingfeng Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Cheng more than expected).

Fields of papers citing papers by Qingfeng Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfeng Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Cheng. The network helps show where Qingfeng Cheng may publish in the future.

Co-authorship network of co-authors of Qingfeng Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfeng Cheng. A scholar is included among the top collaborators of Qingfeng Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfeng Cheng. Qingfeng Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Ruolin, Jun Yang, Yue Wang, et al.. (2024). Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study. Clinical and Experimental Hypertension. 46(1). 2301571–2301571.
2.
Hu, Jinbo, Xiangjun Chen, Yixin Luo, et al.. (2023). Renin-independent aldosteronism and chronic kidney disease in diabetes: Observational and Mendelian randomization analyses. Metabolism. 145. 155593–155593. 8 indexed citations
3.
Ma, Linqiang, Shumin Yang, Yi Yang, et al.. (2023). Phosphoproteomics Reveals the Wolframin-Calcium Axis as an Important Pathogenic Signaling Node in Primary Aldosteronism. Hypertension. 80(5). 995–1010. 7 indexed citations
4.
Cheng, Qingfeng, et al.. (2022). Correlation of peripheral neuropathy with dry eye disease in type 2 diabetic patients. SHILAP Revista de lepidopterología.
5.
Liu, Jie, Qingfeng Cheng, Xiangmei Wu, et al.. (2022). Icariin Treatment Rescues Diabetes Induced Bone Loss via Scavenging ROS and Activating Primary Cilia/Gli2/Osteocalcin Signaling Pathway. Cells. 11(24). 4091–4091. 18 indexed citations
6.
Hu, Jinbo, Hang Shen, Jun Yang, et al.. (2021). Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study. Journal of the American Heart Association. 10(24). e023082–e023082. 29 indexed citations
7.
Yang, Yi, Tracy Ann Williams, Ying Song, et al.. (2020). Nomogram-Based Preoperative Score for Predicting Clinical Outcome in Unilateral Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 105(12). e4382–e4392. 23 indexed citations
8.
Wang, Kanran, Jinbo Hu, Jun Yang, et al.. (2020). Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 105(7). e2449–e2456. 28 indexed citations
9.
Hu, Jinbo, Chuan Peng, Jiayu Li, et al.. (2018). Serum Bisphenol A is an independent risk factor of hyperuricemia: A 6-year prospective study. Seminars in Arthritis and Rheumatism. 48(4). 644–648. 14 indexed citations
10.
Yuan, Zhen, Jun Ki Min, Qingfeng Cheng, et al.. (2018). Quercetin rescued TNF-alpha-induced impairments in bone marrow-derived mesenchymal stem cell osteogenesis and improved osteoporosis in rats.. PubMed. 10(12). 4313–4321. 69 indexed citations
11.
Ma, Linqiang, Ying Song, Mei Mei, et al.. (2018). Age-Related Cutoffs of Plasma Aldosterone/Renin Concentration for Primary Aldosteronism Screening. International Journal of Endocrinology. 2018. 1–10. 38 indexed citations
12.
Yang, Shumin, Aipin Zhang, Ting Li, et al.. (2017). Dysregulated Autophagy in Hepatocytes Promotes Bisphenol A–Induced Hepatic Lipid Accumulation in Male Mice. Endocrinology. 158(9). 2799–2812. 36 indexed citations
13.
Hu, Jinbo, Shumin Yang, Aipin Zhang, et al.. (2016). Associations between abdominal and general obesity and diabetic kidney disease: a cross-sectional study and a prospective study. The Lancet Diabetes & Endocrinology. 4. S35–S35. 1 indexed citations
14.
Yang, Shumin, Ting Luo, Lulu Liu, et al.. (2013). Metformin Inhibits Expression and Secretion of PEDF in Adipocyte and Hepatocyte via Promoting AMPK Phosphorylation. Mediators of Inflammation. 2013. 1–8. 14 indexed citations
15.
Yang, Shumin, Qifu Li, Li Zhong, et al.. (2011). Serum Pigment Epithelium-Derived Factor Is Elevated in Women with Polycystic Ovary Syndrome and Correlates with Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. 96(3). 831–836. 42 indexed citations
16.
Wang, Zhihong, Suhua Zhang, Lilin Gong, et al.. (2009). Association of polymorphisms in transcription factor 7-like 2(TCF7L2) gene with type 2 diabetes in Chinese Han population. Zhonghua neifenmi daixie zazhi. 25(2). 139–143. 2 indexed citations
17.
Cheng, Qingfeng. (2006). Insulin Resistance and Metabolic Syndrome. 2 indexed citations
18.
Li, Weiping, et al.. (2006). Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine. 30(3). 283–287. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026